Cargando…

Therapeutic Applications of Cysteamine and Cystamine in Neurodegenerative and Neuropsychiatric Diseases

Current medications for neurodegenerative and neuropsychiatric diseases such as Alzheimer's disease (AD), Huntington's disease (HD), Parkinson's disease (PD), and Schizophrenia mainly target disease symptoms. Thus, there is an urgent need to develop novel therapeutics that can delay,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Paul, Bindu D., Snyder, Solomon H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Neurology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6920251/ https://www.ncbi.nlm.nih.gov/pubmed/31920936 http://dx.doi.org/10.3389/fneur.2019.01315

Ejemplares similares

Cystamine and cysteamine as inhibitors of transglutaminase activity in vivo
por: Jeitner, Thomas M., et al.
Publicado: (2018)

Cysteamine/Cystamine Exert Anti-Mycobacterium abscessus Activity Alone or in Combination with Amikacin
por: Palucci, Ivana, et al.
Publicado: (2023)

Proceedings: Influence of cysteamine or cystamine on radiation late effects in C57BL/6 mice.
por: Mewissen, D. J., et al.
Publicado: (1975)

Simultaneous Determination of Cysteamine and Cystamine in Cosmetics by Ion-Pairing Reversed-Phase High-Performance Liquid Chromatography
por: Kim, Yejin, et al.
Publicado: (2019)

Cysteamine, an Endogenous Aminothiol, and Cystamine, the Disulfide Product of Oxidation, Increase Pseudomonas aeruginosa Sensitivity to Reactive Oxygen and Nitrogen Species and Potentiate Therapeutic Antibiotics against Bacterial Infection
por: Fraser-Pitt, Douglas J., et al.
Publicado: (2018)

Cystamine Preparations Exhibit Anticoagulant Activity
por: Aleman, Maria M., et al.
Publicado: (2015)

Small Molecules: Therapeutic Application in Neuropsychiatric and Neurodegenerative Disorders
por: Schiavone, Stefania, et al.
Publicado: (2018)

Application of Precision Medicine in Neurodegenerative Diseases
por: Strafella, Claudia, et al.
Publicado: (2018)

Resveratrol-Mediated Regulation of Mitochondria Biogenesis-associated Pathways in Neurodegenerative Diseases: Molecular Insights and Potential Therapeutic Applications
por: Shaito, Abdullah, et al.
Publicado: (2023)

Editorial: Non-invasive Brain Stimulation for Neurodegenerative Disorders: From Investigation to Therapeutic Application
por: Di Lorenzo, Francesco, et al.
Publicado: (2022)

The Role of Gut Microbiota in Neurodegenerative Diseases: Current Insights and Therapeutic Implications
por: Jain, Arpit, et al.
Publicado: (2023)

Editorial: Radiopharmaceuticals, Imaging Techniques and Clinical Applications in Neurodegenerative Diseases
por: Zuo, Chuantao, et al.
Publicado: (2019)

Synthesis and Characterization of Healable Waterborne Polyurethanes with Cystamine Chain Extenders
por: Lee, Dae-Il, et al.
Publicado: (2019)

Immunotherapies for Neurodegenerative Diseases
por: Mortada, Ibrahim, et al.
Publicado: (2021)

Therapeutic Integrity of Microbiome-based Medicines in Neurodegenerative Disorders
por: Kumar, Dhiraj, et al.
Publicado: (2022)

Neuropsychiatric Symptoms of Alzheimer's Disease and Caregiver Burden
por: Iravani, Behnam, et al.
Publicado: (2022)

Editorial: Cerebrovascular and Neurodegenerative Diseases - New Insights Into Molecular Cell Biology and Therapeutic Targets
por: Saha, Sikha, et al.
Publicado: (2019)

Impaired Redox Signaling in Huntington’s Disease: Therapeutic Implications
por: Paul, Bindu D., et al.
Publicado: (2019)

Emerging Promise of Therapeutic Approaches Targeting Mitochondria in Neurodegenerative Disorders
por: Rahman, Md. Mominur, et al.
Publicado: (2023)

The Therapeutic Potential of Mitochondria Transplantation Therapy in Neurodegenerative and Neurovascular Disorders
por: Khan, Mohammad Moshahid, et al.
Publicado: (2023)

Gangliosides: Treatment Avenues in Neurodegenerative Disease
por: Magistretti, Pierre J., et al.
Publicado: (2019)

Effects of Cystamine on antioxidant activities and regulatory T cells in lupus-prone mice
por: Hsu, Tsai-Ching, et al.
Publicado: (2013)

Oxidative stress and antibacterial properties of a graphene oxide-cystamine nanohybrid
por: Nanda, Sitansu Sekhar, et al.
Publicado: (2015)

Neurodegenerative Disease and the Experience of Homelessness
por: Piña-Escudero, Stefanie Danielle, et al.
Publicado: (2021)

Advances in Management of Neuropsychiatric Syndromes in Neurodegenerative Diseases
por: Cummings, Jeffrey, et al.
Publicado: (2019)

The emerging role of furin in neurodegenerative and neuropsychiatric diseases
por: Zhang, Yi, et al.
Publicado: (2022)

Physical exercise and mitochondrial function: New therapeutic interventions for psychiatric and neurodegenerative disorders
por: Sun, Lina, et al.
Publicado: (2022)

Mitochondrial Medicine: A Promising Therapeutic Option Against Various Neurodegenerative Disorders
por: Almikhlafi, Mohannad A., et al.
Publicado: (2023)

Focused Ultrasound Mediated Opening of the Blood-Brain Barrier for Neurodegenerative Diseases
por: Fishman, Paul S., et al.
Publicado: (2021)

The Impact of Vitamin D on Neuropsychiatric Disorders
por: Wassif, Ghada A, et al.
Publicado: (2023)

Neurodegenerative Disease Risk in Carriers of Autosomal Recessive Disease
por: Vieira, Sophia R. L., et al.
Publicado: (2021)

Editorial: Network Spread Models of Neurodegenerative Diseases
por: Raj, Ashish, et al.
Publicado: (2019)

Neuroanatomy of Shared Conversational Laughter in Neurodegenerative Disease
por: Pressman, Peter S., et al.
Publicado: (2018)

On the Use of TMS to Investigate the Pathophysiology of Neurodegenerative Diseases
por: Rawji, Vishal, et al.
Publicado: (2020)

Advances in Proteomic and Metabolomic Profiling of Neurodegenerative Diseases
por: Schumacher-Schuh, Artur, et al.
Publicado: (2022)

Microglia Phenotypes Converge in Aging and Neurodegenerative Disease
por: Candlish, Michael, et al.
Publicado: (2021)

Medicinal Chemistry Studies Against Neurodegenerative Diseases
por: Scotti, Luciana, et al.
Publicado: (2022)

Overview of the Complex Figure Test and Its Clinical Application in Neuropsychiatric Disorders, Including Copying and Recall
por: Zhang, Xiaonan, et al.
Publicado: (2021)

Neuropsychiatric Symptoms in Parkinson's Disease After Subthalamic Nucleus Deep Brain Stimulation
por: Liu, Weibing, et al.
Publicado: (2021)

Fluctuations in Parkinson’s disease and personalized medicine: bridging the gap with the neuropsychiatric fluctuation scale
por: Schmitt, Emmanuelle, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_kn3i6vg63lrictjue8ekn3tbt0